Home » Topics » Regulatory

Regulatory
RSS

Oxeze Turbuhaler approved in Canada for control and relief of asthma symptoms

March 30, 2001

Schering AG's liver-specific contrast agent approved in Sweden

March 30, 2001

Camptosar approved in Canada as first-line treatment of metastatic colorectal cancer

March 29, 2001

Intravenous formulation of Protonix approved by FDA for GERD

March 29, 2001

Enrollment closed in Atrix's phase III trial with four-month Leuprogel

March 29, 2001

Cyamemazine reported to successfully substitute for benzodiazepines

March 27, 2001

Pharmaceutical compositions for obstructive airways disorders claimed by AstraZeneca

March 27, 2001

Expanded use of Visudyne approved in E.U.

March 27, 2001

Schering-Plough receives notification of priority review status for PEG-Intron/Rebetol sBLA

March 27, 2001

Roche seeks FDA approval for Xenical as adjunct in type 2 diabetes

March 23, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...